A total of 20 μg/mL of DKT peritoneally injected in mice halted cancer cell proliferation by enhancing the PAK1/cyclin D1 pathway in neurofibromatosis-derived tumor cells and blocking the signal mainly enacted by protein AKT/AR. The gene discussed is AKT1; the disease is cancer.